Techno Medica Co., Ltd.

Tokyo Stock Exchange 6678.T

Techno Medica Co., Ltd. Revenue Per Share for the year ending March 31, 2024: USD 8.72

Techno Medica Co., Ltd. Revenue Per Share is USD 8.72 for the year ending March 31, 2024, a 4.34% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Techno Medica Co., Ltd. Revenue Per Share for the year ending March 31, 2023 was USD 8.35, a -10.93% change year over year.
Techno Medica Co., Ltd. Revenue Per Share for the year ending March 31, 2022 was USD 9.38, a -2.40% change year over year.
Techno Medica Co., Ltd. Revenue Per Share for the year ending March 31, 2021 was USD 9.61, a -10.55% change year over year.
Techno Medica Co., Ltd. Revenue Per Share for the year ending March 31, 2020 was USD 10.75, a 9.41% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Tokyo Stock Exchange: 6678.T

Techno Medica Co., Ltd.

CEO	Mr. Masatomo Saneyoshi
IPO Date	March 12, 2007
Location	Japan
Headquarters	5-5-1, Nakamachidai
Employees	237
Sector	Health Care
Industries Medical Instruments Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers test tube preparation, automatic urine aliquot, RFID specimen management, and RFID blood transfusion management, as well as blood gas, electrolyte, Erythrocyte Sedimentation Rate, nutrient, sugar and acid, and urine chemistry analyzers; electronic medical charts and pre-analytical instruments; and consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.

Key trends

Past 5 years